Egypt Radiotherapy Market Report 2022 to 2030

Egypt Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Egypt Radiotherapy Market will reach a value of $35 Mn from $19 Mn in 2022, growing at a CAGR of 7.5% during 2022-30. The Radiotherapy Therapeutics Market in Egypt is dominated by a few domestic players such as Accuray, Elekta, and Siemens Healthineers. The radiotherapy market in Egypt is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Egypt Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10EGPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Egypt AUTHOR: Dr. Vishwa Modhia

Buy Now

Egypt Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Egypt Radiotherapy Market will reach a value of $35 Mn from $19 Mn in 2022, growing at a CAGR of 7.5% during 2022-2030.

Egypt is a lower middle-income, developing country in North Africa that borders the Red Sea and the Mediterranean Sea. The number of new cancer cases in Egypt in 2020 was 1,34,632. In 2020, there were 89,042 cancer deaths. Noncommunicable diseases account for 85 % of deaths in Egypt, with cancer being the second most prevalent cause of death (14 %) behind cardiovascular disorders (46%). In Egypt, radiation oncology services are provided by a number of hospitals and clinics. The National Cancer Institute, the Children's Cancer Hospital Egypt, and the Cairo University Hospital are among the well-known ones.

The National Cancer Institute (NCI) is in charge of cancer prevention and control in Egypt through developing and implementing integrated quality programmes in patient treatment, research, education, and prevention. The NCI hospital, which has 550 beds, was erected in phases. It is currently the largest cancer hospital in the Middle East. Many initiatives in oncology have been made over the years to improve cancer prevention, screening, and early diagnosis in Egypt, all of which to better health lead care. Egypt's government spent 4.4% of its GDP on healthcare in 2020.

Egypt Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Egypt approved the Universal Health Insurance (UHI) bill in 2018 to attain universal health coverage as part of Transforming Egypt's Healthcare System Project. The increasing use of technical developments in radiotherapy is fuelling the growth of the radiotherapy market in Egypt. The expanding cancer patient population in the MEA area is driving the growth of the Egypt radiotherapy market.

The increased use of tobacco and alcohol, as well as the adoption of an unhealthy diet, genetic difficulties, and hormonal changes, are all contributing to the rising prevalence of cancer among people. People's awareness of available cancer diagnosis and treatment processes has grown in recent years, which is one of the main reasons for the rising use of radiotherapy in this region. These aspects could boost Egypt's, Radiotherapy Market.

Market restraints

The high cost of therapy is the primary impediment to market expansion in this region. The market's expansion is hampered by a lack of skilled professionals to provide radiotherapy and competent alternative treatment. Increasing problems following radiation potentially poses a threat to market expansion. These factors may deter new entrants into the Egypt Radiotherapy Market.

Competitive Landscape

Key Players

Medical Technology for Trade and Services (MTTS): MTTS is a leading Egyptian company that provides advanced medical equipment and services, including radiotherapy equipment
Naseem Al Rabeeh Medical Center: Naseem Al Rabeeh is a Saudi Arabian company with a significant presence in Egypt, offering comprehensive medical services, including radiation oncology and radiotherapy
Elekta: Elekta is a Swedish company with a strong presence in Egypt, offering advanced radiotherapy solutions for cancer treatment
Varian Medical Systems: Varian is a global leader in radiotherapy and radiation oncology solutions, with a significant presence in Egypt
Siemens Healthineers: Siemens Healthineers is a German multinational medical equipment and services company that provides radiotherapy equipment and solutions in Egypt
Accuracy: Accuracy is a US-based company that offers innovative radiation therapy solutions for cancer treatment, including the CyberKnife system, which is available in Egypt

Recent Notable Updates

February 2021: Elekta, the Swedish radiotherapy giant, has announced the opening of a new office in Cairo, Egypt, to expand its radiotherapy hardware and software business on the African continent. According to the Directory of Radiotherapy Centres, radiation treatment machines are known to exist in 30 African countries, with 240 radiotherapy centres and a total of 509 machines, the majority of which are in South Africa (129) and Egypt (143). The new Elekta office will serve as a hub for the company's precision radiation therapy solutions to be marketed in Egypt and neighbouring countries.

Healthcare Policies and Reimbursement Scenarios

In Egypt, the regulations and reimbursement of radiotherapy are overseen by the Egyptian Ministry of Health and Population (MoHP) and the Health Insurance Organization (HIO). The MoHP is responsible for regulating the use of radiation in Egypt, including the use of radiotherapy. The reimbursement rates for radiotherapy in Egypt are relatively low compared to other countries, which can result in financial challenges for healthcare providers and patients.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.